Release Date: 28/04/23 08:14 Summary: Appendix 4C - Q4FY23 Quarterly Cash Flow Report Price Sensitive: Yes Download Document 526.63KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status